Categorias DeCS
C04 Neoplasms .
C04.445 Hamartoma .
C04.445.810 Tuberous Sclerosis .
C04.651 Neoplasms, Multiple Primary .
C04.651.800 Tuberous Sclerosis .
C04.700 Neoplastic Syndromes, Hereditary .
C04.700.632 Tuberous Sclerosis .
C10 Nervous System Diseases .
C10.500 Nervous System Malformations .
C10.500.507 Malformations of Cortical Development .
C10.500.507.400 Malformations of Cortical Development, Group I .
C10.500.507.400.750 Tuberous Sclerosis .
C10.562 Neurocutaneous Syndromes .
C10.562.850 Tuberous Sclerosis .
C10.574 Neurodegenerative Diseases .
C10.574.500 Heredodegenerative Disorders, Nervous System .
C10.574.500.865 Tuberous Sclerosis .
C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities .
C16.131 Congenital Abnormalities .
C16.131.666 Nervous System Malformations .
C16.131.666.507 Malformations of Cortical Development .
C16.131.666.507.400 Malformations of Cortical Development, Group I .
C16.131.666.507.400.750 Tuberous Sclerosis .
C16.320 Genetic Diseases, Inborn .
C16.320.400 Heredodegenerative Disorders, Nervous System .
C16.320.400.880 Tuberous Sclerosis .
C16.320.700 Neoplastic Syndromes, Hereditary .
C16.320.700.636 Tuberous Sclerosis .
C23 Pathological Conditions, Signs and Symptoms .
C23.550 Pathologic Processes .
C23.550.823 Sclerosis .
D02 Organic Chemicals .
D02.886 Sulfur Compounds .
D02.886.640 Sulfoxides .
D02.886.640.150 Dimethyl Sulfoxide .
D26 Pharmaceutical Preparations .
D26.776 Solutions .
D26.776.708 Pharmaceutical Solutions .
D26.776.708.822 Sclerosing Solutions .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.954 Therapeutic Uses .
D27.505.954.411 Cardiovascular Agents .
D27.505.954.411.700 Sclerosing Solutions .
D27.505.954.578 Pharmaceutical Solutions .
D27.505.954.578.822 Sclerosing Solutions .
D27.720 Specialty Uses of Chemicals .
D27.720.752 Pharmaceutical Solutions .
D27.720.752.822 Sclerosing Solutions .
|
| | Termos
Sinônimos e Históricos | Documentos
LILACS e MDL | | | | | | | | | | | | | |
|
